Mr Michael Mirabello, BA in Plainville, CT - Counselor

Mr Michael Mirabello, BA is a Counselor based in Plainville, Connecticut. Mr Michael Mirabello is licensed to practice in * (Not Available) (license number ) and his current practice location is 91 Northwest Dr, Plainville, Connecticut. He can be reached at his office (for appointments etc.) via phone at (860) 793-3717.

NPI number for Mr Michael Mirabello is 1063771491 and his current mailing address is 91 Northwest Dr, Plainville, Connecticut. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1063771491.

Contact Information

	Mr Michael Mirabello, BA
	91 Northwest Dr, Plainville, CT 06062-1534
	(860) 793-3717
	Not Available

Healthcare Provider's Profile

Full Name	Mr Michael Mirabello
Gender	Male
Speciality	Counselor
Location	91 Northwest Dr, Plainville, Connecticut
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1063771491
Provider Enumeration Date: 05/04/2012
Last Update Date: 05/04/2012

Medical Identifiers

Medical identifiers for Mr Michael Mirabello such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1063771491	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
101Y00000X	Counselor	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Michael Mirabello is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Michael Mirabello, BA 91 Northwest Dr, Plainville, CT 06062-1534 Ph: (860) 793-3717	Mr Michael Mirabello, BA 91 Northwest Dr, Plainville, CT 06062-1534 Ph: (860) 793-3717

News Archive

drchrono closes $2.8 million round of funding

drchrono, the company that is transforming the focus of healthcare from the enterprise to the provider, today announced it has closed a $2.8 million round of funding led by Yuri Milner and featuring new investors that share a legacy of innovation and business transformation.

SRC-3 gene sends signal to cell membrane to promote cell motility

The master gene called SRC-3 (steroid receptor coactivator 3) not only enhances estrogen-dependent growth of cancer cells by activating and encouraging the transcription of a genetic message into a protein, it also sends a signal to the cell membrane to promote cell motility or movement - a key element of cancer spread or metastasis, said Baylor College of Medicine (www.bcm.edu) researchers and collaborators in a report that appears in the current issue of the journal Molecular Cell.

BrainStorm completes registered public offering of common stock

BrainStorm Cell Therapeutics Inc., an innovative developer of adult stem cell technologies and Central Nervous System (CNS) therapeutics, today announced that it completed a registered public offering of 19,818,972 shares of common stock at a price per share of $0.29 and warrants to purchase 14,864,229 shares of common stock at an exercise price of $0.29 per share, representing gross proceeds of $5,747,502.

EU gives 32 million Euro for vaccines to stop tuberculosis

The European Commission today launched the largest-ever collaborative tuberculosis (TB) initiative for World TB-day, March 24. Fifty-two research teams from academia and industry from 15 European and African countries are joining forces with the European Commission to help eradicate TB. Globally, TB kills 2 million people a year, with one-third of the world's population currently infected with the bacillus, Mycobacterium tuberculosis (Mtb). While most cases and deaths occur in developing countries, resistant Mtb strains are mainly found among the poorest people in developed countries, as incomplete treatment increases drug resistance. The European Union is confronting the re-emerging threat of TB by investing €32 million in two overlapping research projects. This cash will be used in an accelerated effort to develop new, effective vaccines to fight TB.

Huntingtin protein plays critical role in long-term memory development

It has been more than 20 years since scientists discovered that mutations in the gene huntingtin cause the devastating progressive neurological condition Huntington's disease, which involves involuntary movements, emotional disturbance and cognitive impairment.

Counselor in Plainville, CT

Jonathan Codraro, M.S Counselor Medicare: Not Enrolled in Medicare Practice Location: 74 East St, Plainville, CT 06062 Phone: 860-466-9646
Mr. Lewis Alan Slotnick, M.S. LADC ICADC SAP Counselor Medicare: Not Enrolled in Medicare Practice Location: 74 East St, Plainville, CT 06062 Phone: 800-522-3271
Ciyauah Lashawn Daniels, Counselor Medicare: Not Enrolled in Medicare Practice Location: 74 East St, Plainville, CT 06062 Phone: 860-793-4200
Julia Zarovny, BA Counselor Medicare: Not Enrolled in Medicare Practice Location: 91 Northwest Dr, Plainville, CT 06062 Phone: 860-793-3500
Eliz Cruz, MS Counselor Medicare: Not Enrolled in Medicare Practice Location: 91 Northwest Dr, Plainville, CT 06062 Phone: 860-793-3500
Mr. Viktor A Gonzalez, Counselor Medicare: Not Enrolled in Medicare Practice Location: 91 Northwest Dr, Plainville, CT 06062 Phone: 860-793-3500
Stacey Brown, Counselor Medicare: Not Enrolled in Medicare Practice Location: 91 Northwest Dr, Plainville, CT 06062 Phone: 860-223-8885

Mr Michael Mirabello, BA - Counselor in Plainville, CT